Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris de Laet

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|May 19, 2009
How many CIN2+ lesions can be avoided through HPV 16/18 vaccination?Frank Hulstaert, Chris De Laet
Health Policy (Amsterdam, Netherlands)|March 26, 2013
Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalitiesIrina Cleemput, Chris De Laet
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
The use of instrumental variables: an alternative to traditional modeling?Mattias Neyt, Hans Van Brabandt, Chris De Laet
Journal of Epidemiology and Community Health|February 16, 2006
The polypill: at what price would it become cost effective?Oscar H Franco, Ewout W Steyerberg, Chris de Laet
Health Policy (Amsterdam, Netherlands)|May 22, 2012
Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational dataMattias Neyt, Irina Cleemput, Nancy Thiry, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 21, 2012
Legal and organizational aspects of remote cardiac monitoring: the example of implantable cardioverter defibrillatorsImgard Vinck, Chris De Laet, Serge Stroobandt, et al.
Hypertension (Dallas, Tex. : 1979)|June 29, 2005
Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysisOscar H Franco, Anna Peeters, Luc Bonneux, et al.
Health Policy (Amsterdam, Netherlands)|January 13, 2009
Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literatureMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
Pharmacoeconomics|June 3, 2009
Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspectiveMattias Neyt, Chris De Laet, Annemieke De Ridder, et al.
International Journal of Technology Assessment in Health Care|January 26, 2011
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisionsIrina Cleemput, Mattias Neyt, Nancy Thiry, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Acta Obstetricia Et Gynecologica Scandinavica|May 19, 2009
How many CIN2+ lesions can be avoided through HPV 16/18 vaccination?Frank Hulstaert, Chris De Laet
Health Policy (Amsterdam, Netherlands)|March 26, 2013
Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalitiesIrina Cleemput, Chris De Laet
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2011
The use of instrumental variables: an alternative to traditional modeling?Mattias Neyt, Hans Van Brabandt, Chris De Laet
Journal of Epidemiology and Community Health|February 16, 2006
The polypill: at what price would it become cost effective?Oscar H Franco, Ewout W Steyerberg, Chris de Laet
Health Policy (Amsterdam, Netherlands)|May 22, 2012
Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational dataMattias Neyt, Irina Cleemput, Nancy Thiry, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 21, 2012
Legal and organizational aspects of remote cardiac monitoring: the example of implantable cardioverter defibrillatorsImgard Vinck, Chris De Laet, Serge Stroobandt, et al.
Hypertension (Dallas, Tex. : 1979)|June 29, 2005
Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysisOscar H Franco, Anna Peeters, Luc Bonneux, et al.
Health Policy (Amsterdam, Netherlands)|January 13, 2009
Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literatureMattias Neyt, Hans Van Brabandt, Stephan Devriese, et al.
Pharmacoeconomics|June 3, 2009
Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspectiveMattias Neyt, Chris De Laet, Annemieke De Ridder, et al.
International Journal of Technology Assessment in Health Care|January 26, 2011
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisionsIrina Cleemput, Mattias Neyt, Nancy Thiry, et al.
Pageof 4